Frank Schonlau, PhD
Dr. Frank Schonlau's fundamental intrigue and belief in the role of preventative nutritional intervention for degenerative conditions has been a guiding force in his career and outlook. He has published scores of articles in peer reviewed international basic science and medical journals on the role and efficacy of bioflavonoids in disease states. This passion has led to a natural career progression as the present Director of Science Communication of Horphag, Research UK - a leader in bioflavonoid research and development. In this position, Dr. Schonlau is a guiding force for research efforts and scientific communication as he advances our understanding of oxidative stress, the efficacy and mechanisms of bioflavonoids in health.
An accomplished research biochemist, Dr. Schonlau's career commenced with research and development of tumor specific anti-cancer drugs as part of the European Community research program "Europe against Cancer" at the University Clinics of Munster, Germany. Later, Dr. Schonlau continued his research on anti-cancer drup development and worked on the synthesis of melatonin derivatives for improved bioavailability at the Haddo Laboratories, Royal Hospital in Sutton Surry, UK. At the Institute of Experimental Dermatology, University Clinics of Munster Germany, Dr. Schonlau investigated inflammatory processes, would healing, vascular disorders and angiogenesis. A graduate of the University of Munster, Germany, Dr. Schonlau received his PhD in biochemistry.
